Our goal is to develop new and improved medicines through innovative research, create and validate innovative diagnostic tests, and provide services that offer significant benefits over existing options for patients.
We aim to improve the standard of care across a number of areas including oncology, haematology, neuroscience, inflammation, immunology, ophthalmology, rare diseases, cardiovascular diseases, and respiratory diseases.